OncoSynergy
-
2011
Company Description
OncoSynergy improve outcomes for patients with unmet need in oncology with Resistance Mechanism Inhibitors (RMIs).
The vision of OncoSynergy, a UCSF spin-out, is to radically improve outcomes for patients with unmet need in oncology with Resistance Mechanism Inhibitors (RMIs). This new class of therapeutics simultaneously targets multiple hallmarks of cancer progression and have demonstrated dramatic preclinical efficacy as monotherapy and in strategic combinations.
-
Manufacturer:
Science and Engineering -
Formed:
2011 -
Company Website:
-
Company E-mail:
-
Company Address:
409 Illinois StreetSan Francisco, CAUnited States -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits